# Development of Preclinical Models Derived From Tumors With a Molecular Abnormality of Interest to Test Their Sensitivity to New Anti-tumor Therapies.

> **NCT06782451** · NA · RECRUITING · sponsor: **Centre Antoine Lacassagne** · enrollment: 50 (estimated)

## Conditions studied

- Neoplasm Malignant

## Interventions

- **PROCEDURE:** Surgery or biopsy
- **PROCEDURE:** Blood sample

## Key facts

- **NCT ID:** NCT06782451
- **Lead sponsor:** Centre Antoine Lacassagne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-02
- **Primary completion:** 2030-07-02
- **Final completion:** 2030-07-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06782451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06782451, "Development of Preclinical Models Derived From Tumors With a Molecular Abnormality of Interest to Test Their Sensitivity to New Anti-tumor Therapies.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06782451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*